In a mouse model of checkpoint blockade immunotherapy, d42m1 clone T3 tumor cells could grow in wild-type mice, but were rejected following anti-PD-1 or anti-CTLA-4 immunotherapy [127]. Here, CTLA4 is linked to neoplasm.